The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 3-(4-(6-(5-(2,4-difluorophenylsulfonamido)-6-methoxypyridin-3-yl)-2H-benzo[b][1,4]oxazin-3-yl)piperazin-1-yl)propanoate ID: ALA4251404
PubChem CID: 145986059
Max Phase: Preclinical
Molecular Formula: C28H29F2N5O6S
Molecular Weight: 601.63
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COCC(=O)CN1CCN(C2=Nc3cc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5F)c4)ccc3OC2)CC1
Standard InChI: InChI=1S/C28H29F2N5O6S/c1-39-16-21(36)15-34-7-9-35(10-8-34)27-17-41-25-5-3-18(11-23(25)32-27)19-12-24(28(40-2)31-14-19)33-42(37,38)26-6-4-20(29)13-22(26)30/h3-6,11-14,33H,7-10,15-17H2,1-2H3
Standard InChI Key: FDCVHQXLEPXDFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
11.8163 -13.1452 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2290 -12.4395 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.4114 -12.4349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2331 -14.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2331 -14.8952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9384 -15.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6437 -14.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6437 -14.0780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9384 -13.6653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3503 -15.3082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3472 -16.1263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0502 -16.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0565 -14.8996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7641 -15.3136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7574 -16.1335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4602 -16.5468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1741 -16.1449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1807 -15.3251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4735 -14.9072 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9384 -12.8481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5242 -13.6715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8177 -14.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2249 -11.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8921 -14.9230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5927 -15.3390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3020 -14.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3137 -14.1229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6099 -13.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8944 -14.1060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9328 -11.2119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9290 -10.3955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2187 -9.9897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5107 -10.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5180 -11.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6418 -11.6183 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.2135 -9.1725 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.0266 -13.7234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0371 -12.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3347 -12.4886 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7500 -12.5069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7605 -11.6897 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4734 -11.2903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 9 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
10 11 1 0
10 13 2 0
11 12 2 0
12 15 1 0
14 13 1 0
7 10 1 0
14 15 2 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
9 20 1 0
20 2 1 0
4 21 1 0
21 22 1 0
2 23 1 0
18 24 1 0
24 25 1 0
24 29 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
23 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 23 1 0
30 35 1 0
32 36 1 0
27 37 1 0
37 38 1 0
38 39 2 0
38 40 1 0
40 41 1 0
41 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 601.63Molecular Weight (Monoisotopic): 601.1807AlogP: 3.09#Rotatable Bonds: 9Polar Surface Area: 122.66Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.58CX Basic pKa: 5.57CX LogP: 2.05CX LogD: 1.65Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.39Np Likeness Score: -1.36
References 1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW.. (2018) Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors., 26 (14): [PMID:29937355 ] [10.1016/j.bmc.2018.06.022 ]